Yuhan Corporation makes a 1 billion KRW joint investment in GenomeOpinion to develop customized treatment for chronic diseases

Funding Rounds

▤ Summary

Yuhan Corporation is making a joint 10 billion won investment in GenomeOpinion to develop customized treatments for chronic diseases. The piece ties the investment to genomics, bioinformatics, and AI-driven R&D rather than a consumer product or hardware story. This points to software and data analytics supporting life sciences research and precision medicine. The event suggests continued capital flow into healthcare software and AI-enabled pharmaceutical development.

$ Funding

$
Amount $4.3M Total raised
□
Date January 1, 2020 Announcement date
◎
Investors - Lead investors
▥
Company https://www.nobomedicine.com/ Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies